Mishal Javed BDS, MSc.

Department of Applied Health Sciences
Research Fellow

Contact details

Address
Health Economics Unit
Building Y16
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Mishal Javed is a health economist, with a background in dental sciences, and considerable experience in research, costing studies, economic evaluations, decision analytic modelling, and health financing. She is currently working as a Research Fellow at the Health Economics Unit, University of Birmingham. 

ORCiD iD: 0009-0007-5095-4231

Qualifications

  • Master’s in Health Economics, University of York, UK, 2020
  • Bachelor of Dental Surgery, Riphah International University, Pakistan, 2017

Biography

Mishal Javed holds a Bachelor's degree in Dentistry from Pakistan. After working as a dentist for two years, she transitioned into the field of health economics, driven by a desire to impact healthcare systems beyond clinical practice. In 2019, she pursued an MSc in Health Economics at the University of York, which she completed with distinction in 2020.

Before joining Health Economics Unit, Mishal worked in Pakistan in Health Financing at the Ministry of Health, in a policy-oriented role, where she worked on a number of diverse projects, and collaborated with national and international stakeholders.

Mishal joined the Health Economics Unit, University of Birmingham, as a Research Fellow in 2023. In this capacity, she has worked with Dr Jesse Kigozi, Professor Louise Jackson, and Professor Sue Jowett on a number of trial-based economic evaluations related to maternal health, vascular surgery, and pain management.

Mishal is also doing a part-time PhD in Health Economics and Policy from Lancaster University. 

Research

Mishal has worked on a number of projects, including trial-based cost-consequence analysis of planned early term delivery or usual care at term for pregnant women with chronic or gestational hypertension; within-trial cost-effectiveness and cost-utility analyses of drug-coated balloons, drug-eluting stents, and plain balloon angioplasty with bail-out bare metal stent revascularisation strategies, for severe leg ischemia due to atherosclerotic femoropopliteal and/or infrapopliteal peripheral artery disease; and trial-based cost-utility analysis of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain. Currently, she is working on a within-trial and model-based cost-utility analyses of proactive clinical review of patients taking opioid medicines long-term for persistent pain led by clinical pharmacists in primary care teams.

Publications

Magee, L.A., Kirkham, K., Tohill, S., Gkini, E., Moakes, C.A., Dorling, J., Green, M., Hutcheon, J.A., Javed, M., Kigozi, J. and Mol, B.W., 2024. Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial. PLoS Medicine21(11), p.e1004481.

View all publications in research portal